| Value | ₹19.54 Cr |
|---|
NSE filing, NSE: HARDWYN. Summary written from the filing by ALFA Finder's alert engine.
Hardwyn India Ltd: key numbers
- Share price
- ₹9.12
- Market cap
- ₹623.6 Cr
- Revenue (annual)
- ₹199.9 Cr
- Net profit (annual)
- ₹13.21 Cr
- P/E (TTM)
- 47.2×Sector 42.1×
- Promoter holding
- 43.77%+0.00% QoQ
- FII holding
- 0.12%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Hardwyn India Ltd
All →Hardwyn India Other Announcement
Hardwyn India Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, per SEBI (LODR) Regulations. This is a routine compliance disclosure.
Hardwyn India Other Announcement
Hardwyn India Limited received a three-month extension from the ROC to hold its Annual General Meeting for the financial year ended March 31, 2026.
Hardwyn India Legal & Regulatory
Hardwyn India's board noted a ₹0.0325 Cr exchange fine for LODR board-composition non-compliance. The company has rectified the lapse and is seeking a waiver.
- Value
- ₹0.03 Cr
Hardwyn India Other Announcement
Hardwyn India Limited received an extension of three months from the Registrar of Companies to conduct its Annual General Meeting for the financial year 2025-26.
Hardwyn India Management Change
Hardwyn India Limited appointed Mr. Eakam Sayal as an Additional, Non-executive, and Non-Independent Director, effective August 29, 2026.
Hardwyn India Q1 FY27 Results: Net Profit ₹2.8 Cr, Down 22.2% YoY
Hardwyn India Ltd reported revenue from operations of ₹34.6 Cr (-19.3% YoY) and net profit of ₹2.8 Cr (-22.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹2.8 Cr · -22.2% YoY
Other bonus issue announcements
All →Shreeji Global FMCG Bonus Issue
Shreeji Global FMCG board recommended a 1:1 bonus issue funded from securities premium, with no cash paid. Paid-up capital rises from Rs.22.76 Crore to Rs.49.92 Crore.
Concord Biotech Bonus Issue
Concord Biotech fixed 4 November 2026 as the record date for a 1:1 bonus issue, with deemed allotment on 5 November 2026. The bonus is subject to statutory and regulatory approvals.
Anlon Technology Solutions Bonus Issue
Anlon Technology Solutions fixed 02-Nov-2026 as the record date for its 2:5 bonus issue of equity shares. The bonus is free shares from reserves, with no cash paid.
Concord Biotech Bonus Issue
Concord Biotech's postal ballot approved a bonus issue and an authorised capital increase. No cash is paid and no ratio is stated.
Titan Biotech Bonus Issue
Titan Biotech allotted 1,03,29,625 bonus shares of Rs. 2 each in a 1:4 ratio. Paid-up capital rose to Rs. 10.33 Crore post-allotment.
Utssav CZ Gold Jewels Bonus Issue
Utssav CZ Gold Jewels' board recommended a 1:1 bonus issue from free reserves on 23 October 2026. Paid-up capital rises from Rs.25.00 Crore to Rs.50.00 Crore, subject to AGM/postal ballot on 25 November 2026.